Subscribe To
AMRX / FDA Accepts Amneal's (AMRX) Parkinson's Candidate NDA For Review
AMRX News
By Zacks Investment Research
October 25, 2023
Amneal (AMRX) Upgraded to Buy: Here's Why
Amneal (AMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the sto more_horizontal
By Zacks Investment Research
October 25, 2023
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
Here is how Amneal Pharmaceuticals (AMRX) and KalVista Pharmaceuticals, Inc. (KALV) have performed compared to their sector so far this year. more_horizontal
By Zacks Investment Research
October 17, 2023
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal
By Zacks Investment Research
October 6, 2023
Here Is Why Bargain Hunters Would Love Fast-paced Mover Amneal (AMRX)
Amneal (AMRX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gai more_horizontal
By PennyStocks
August 7, 2023
Penny Stocks To Buy? 5 To Watch With Big News This Week
Investors often rely on stock market news to stay abreast of everything, ranging from low-cost penny stocks to industry giants such as Apple or Tesla. more_horizontal
By Zacks Investment Research
August 4, 2023
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compa more_horizontal
By Zacks Investment Research
July 21, 2023
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal
By The Motley Fool
July 5, 2023
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday
Amneal has more than 270 products. On Tuesday, the company launched a generic for Xyrem to treat excessive daytime sleepiness. more_horizontal